{
    "Trade/Device Name(s)": [
        "Wondfo Methadone Urine Test (MTD 200)",
        "Wondfo Morphine Urine Test (MOP 100)"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K131232",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050394"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "DJG"
    ],
    "Summary Letter Date": "May 31, 2013",
    "Summary Letter Received Date": "May 6, 2013",
    "Submission Date": "April 26, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3620",
        "21 CFR 862.3640"
    ],
    "Regulation Name(s)": [
        "Methadone test system",
        "Morphine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methadone",
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Dip Card",
        "Cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Methadone Urine Test (MTD 200) and Wondfo Morphine Urine Test (MOP 100) for qualitative detection of methadone and morphine in human urine.",
    "Indications for Use Summary": "Qualitative immunochromatographic assays for prescription use to detect methadone (200 ng/mL) and morphine (100 ng/mL) in human urine, not for point-of-care use; preliminary results requiring confirmation by alternative chemical methods.",
    "fda_folder": "Toxicology"
}